Border to Coast Pensions Partnership’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361M Sell
1,932,961
-116,697
-6% -$21.9M 5.33% 3
2026
Q1
$398M Buy
+2,049,658
New +$395M 6.73% 1

Other funds holding AZN

Border to Coast Pensions Partnership's AZN Position: Q2 2026 in Review

Border to Coast Pensions Partnership reduced its AstraZeneca (AZN) stake by 5.7% in Q2 2026, selling an estimated $21.9M and leaving 1,932,961 shares worth $361M. The position accounts for 5.33% of the portfolio, ranked #3.

Border to Coast Pensions Partnership first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $398M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Border to Coast Pensions Partnership held 1,932,961 shares of AstraZeneca worth $361M as of Q2 2026.
  • Border to Coast Pensions Partnership sold 116,697 AstraZeneca shares in Q2 2026, an estimated $21.9M.
  • AstraZeneca made up 5.33% of Border to Coast Pensions Partnership's portfolio in Q2 2026, its #3 holding.
  • Border to Coast Pensions Partnership first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • Border to Coast Pensions Partnership's AstraZeneca position peaked at $398M in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Border to Coast Pensions Partnership's 13F filing for Q2 2026, filed 27 Jul 2026.